Skip to main content
placeholder image

Initial survival outcomes for the AGITG GAP study ��� a phase II study of perioperative nab -paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC).

Journal Article


Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)

Publication Date


  • 2016

Web Of Science Accession Number


Start Page


  • 4105

End Page


  • 4105

Volume


  • 34

Issue


  • 15_suppl

Place Of Publication


Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)

Publication Date


  • 2016

Web Of Science Accession Number


Start Page


  • 4105

End Page


  • 4105

Volume


  • 34

Issue


  • 15_suppl

Place Of Publication